Literature DB >> 10149136

Methods for improving drug release from poly(methyl)methacrylate bone cement.

S Downes1.   

Abstract

Poly(methylmethacrylate) (PMMA) is a widely used material with both dental and orthopaedic applications. The acrylic cement is produced by the combination of polymethylacrylate beads with methylmethacrylate monomer. After polymerisation, a heterogeneous and porous matrix is formed which can be used to deliver therapeutic agents. In this work, the release of antibiotic, growth hormone and serum albumin is demonstrated. The mechanism is similar for all agents; a rapid release followed by a slow continuous release. The quantity of drug released depends upon the formulation of both the PMMA and the drug. The polymer-to-monomer ratio can greatly affect the ratio of drug release; increased polymer-to-monomer ratio leads to increased release of antibiotic. Optimum release is achieved if a crystalline formulation of the drug is used rather than a fine powder. Experimental methods to improve the drug release performance of bone cements are presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 10149136     DOI: 10.1016/0267-6605(91)90063-l

Source DB:  PubMed          Journal:  Clin Mater        ISSN: 0267-6605


  5 in total

1.  Liquid dextran does not increase the elution rate of different antibiotics from bone cement.

Authors:  K E Roth; B Krause; E Siegel; G Maier; C Schoellner; P M Rommens
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-01-11

2.  Gentamicin release from commercially-available gentamicin-loaded PMMA bone cements in a prosthesis-related interfacial gap model and their antibacterial efficacy.

Authors:  Daniëlle Neut; Otto S Kluin; Jonathan Thompson; Henny C van der Mei; Henk J Busscher
Journal:  BMC Musculoskelet Disord       Date:  2010-11-10       Impact factor: 2.362

3.  Hydrogels based on chitosan and dextran as potential drug delivery systems.

Authors:  M G Cascone; S Maltinti
Journal:  J Mater Sci Mater Med       Date:  1999-05       Impact factor: 3.896

4.  Methotrexate released in vitro from bone cement inhibits human stem cell proliferation in S/G2 phase.

Authors:  Egon Prochazka; Tomas Soukup; Milos Hroch; Leos Fuksa; Eva Brcakova; Jolana Cermanova; Gabriela Kolouchova; Karel Urban; Jaroslav Mokry; Stanislav Micuda
Journal:  Int Orthop       Date:  2009-02-11       Impact factor: 3.075

5.  Copal bone cement is more effective in preventing biofilm formation than Palacos R-G.

Authors:  Geert T Ensing; Jim R van Horn; Henny C van der Mei; Henk J Busscher; Daniëlle Neut
Journal:  Clin Orthop Relat Res       Date:  2008-03-13       Impact factor: 4.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.